These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9344366)

  • 1. Treatment of major depression: selection of initial drug.
    Potter WZ; Schmidt ME
    Mod Probl Pharmacopsychiatry; 1997; 25():1-16. PubMed ID: 9344366
    [No Abstract]   [Full Text] [Related]  

  • 2. Star-D: lessons learned and future implications.
    Rush AJ
    Depress Anxiety; 2011 Jul; 28(7):521-4. PubMed ID: 21721070
    [No Abstract]   [Full Text] [Related]  

  • 3. Digging for data on harms in duloxetine trials.
    Doshi P; Zito J; dosReis S
    BMJ; 2014 Jun; 348():g3578. PubMed ID: 24904123
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors in children and adolescents with major depression.
    Scahill L
    Braz J Psychiatry; 2005 Jun; 27(2):91-2. PubMed ID: 15962129
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evidence for psychopharmacological treatment of depression in children and adolescents?].
    Thomsen PH; Sørensen MJ
    Ugeskr Laeger; 2007 Apr; 169(14):1289-94. PubMed ID: 17437688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuation treatment with antidepressants in child and adolescent major depression.
    Ryan ND
    Am J Psychiatry; 2008 Apr; 165(4):411-2. PubMed ID: 18381908
    [No Abstract]   [Full Text] [Related]  

  • 7. ACS chemical neuroscience molecule spotlight on viibryd (Vilazodone).
    Hopkins CR
    ACS Chem Neurosci; 2011 Oct; 2(10):554. PubMed ID: 22860155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vortioxetine for Depression in Adults.
    Long JD
    Issues Ment Health Nurs; 2019 Sep; 40(9):819-820. PubMed ID: 31225773
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitor treatment of major depressive disorder in children and adolescents.
    Newcorn JH
    Curr Psychiatry Rep; 2004 Apr; 6(2):85-7. PubMed ID: 15038909
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs which influence serotonin transporter and serotonergic receptors: Pharmacological and clinical properties in the treatment of depression.
    Taciak PP; Lysenko N; Mazurek AP
    Pharmacol Rep; 2018 Feb; 70(1):37-46. PubMed ID: 29309998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agomelatine versus other antidepressive agents for major depression.
    Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD008851. PubMed ID: 24343836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicidality in pediatric patients treated with antidepressant drugs.
    Hammad TA; Laughren T; Racoosin J
    Arch Gen Psychiatry; 2006 Mar; 63(3):332-9. PubMed ID: 16520440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode.
    Martinez JM; Katon W; Greist JH; Kroenke K; Thase ME; Meyers AL; Edwards SE; Marangell LB; Shoemaker S; Swindle R
    Int Clin Psychopharmacol; 2012 Jan; 27(1):17-26. PubMed ID: 22027844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of antidepressants to treat depression in children and adolescents.
    Cheung AH; Emslie GJ; Mayes TL
    CMAJ; 2006 Jan; 174(2):193-200. PubMed ID: 16415467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Milnacipran versus other antidepressive agents for depression.
    Nakagawa A; Watanabe N; Omori IM; Barbui C; Cipriani A; McGuire H; Churchill R; Furukawa TA
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD006529. PubMed ID: 19588396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.
    Foley P; Lawler A; Chandran S; Mead G
    J Neurol Neurosurg Psychiatry; 2014 Jun; 85(6):709-10. PubMed ID: 24403283
    [No Abstract]   [Full Text] [Related]  

  • 18. Should we use antidepressants for the treatment of major depressive disorder in children and adolescents?
    Birmaher B; Brent D
    Braz J Psychiatry; 2005 Jun; 27(2):89-90. PubMed ID: 15962128
    [No Abstract]   [Full Text] [Related]  

  • 19. Violent parasomnia associated with a selective serotonin reuptake inhibitor: a case report.
    Khawaja IS; Hurwitz TD; Schenck CH
    J Clin Psychiatry; 2008 Dec; 69(12):1982-3. PubMed ID: 19203482
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
    Brent DA
    Depress Anxiety; 2009; 26(10):871-4. PubMed ID: 19798756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.